Steven E. Kahn, MB, ChB is a Professor of Medicine in the Division of Metabolism, Endocrinology and Nutrition at the VA Puget Sound Health Care System and University of Washington in Seattle, Washington. He directs the Diabetes Research Center at the University of Washington.
Dr. Kahn’s research interests include the role of β-cell in the pathogenesis and treatment of prediabetes and type 2 diabetes. He has performed physiological studies characterizing β-cell function in individuals with diabetes and those at increased risk and is an active participant in a number of large multicenter clinical trials in which interventions are being tested to prevent and treat type 2 diabetes. Aside from his clinical studies, he has an extensive basic research program examining the role of islet amyloid in the loss of β-cells in type 2 diabetes.
He has received numerous awards for his research including the Novartis Young Investigator in Diabetes Award, American Diabetes Association Distinguished Clinical Scientist Award, The Endocrine Society Clinical Investigator Award, United States Department of Veterans Affairs John B. Barnwell Award, and European Association for the Study of Diabetes Albert Renold Award. He has been elected to membership in the American Society for Clinical Investigation and the American Association of Physicians.Back to Editorial Board